Published in Transplantation on February 27, 2002
Survival after liver transplantation using hepatitis C virus-positive donor allografts: case-controlled analysis of the UNOS database. World J Surg (2011) 1.57
PHS guideline for reducing human immunodeficiency virus, hepatitis B virus, and hepatitis C virus transmission through organ transplantation. Public Health Rep (2013) 1.17
Risk of advanced fibrosis with grafts from hepatitis C antibody-positive donors: a multicenter cohort study. Liver Transpl (2012) 0.88
Utilization of expanded criteria donors in liver transplantation. Int J Organ Transplant Med (2013) 0.83
Changing pattern of donor selection criteria in deceased donor liver transplant: a review of literature. J Clin Exp Hepatol (2013) 0.80
Developments in liver transplantation. Gut (2004) 0.79
Graft calcifications and dysfunction following liver transplantation. BMC Surg (2004) 0.78
Phenotypic and genotypic differences between a child with vertically acquired severe hepatitis C liver disease and his mother. J Pediatr Gastroenterol Nutr (2012) 0.75
Urinary-cell mRNA profile and acute cellular rejection in kidney allografts. N Engl J Med (2013) 7.40
Outcomes of kidney transplantation in HIV-infected recipients. N Engl J Med (2010) 6.26
Outcomes of liver transplant recipients with hepatitis C and human immunodeficiency virus coinfection. Liver Transpl (2012) 4.65
Innate lymphoid cells promote anatomical containment of lymphoid-resident commensal bacteria. Science (2012) 4.20
Homeostatic proliferation is a barrier to transplantation tolerance. Nat Med (2003) 4.12
Therapeutic siRNA silencing in inflammatory monocytes in mice. Nat Biotechnol (2011) 3.95
Functional restoration of HCV-specific CD8 T cells by PD-1 blockade is defined by PD-1 expression and compartmentalization. Gastroenterology (2008) 2.95
Informing candidates for solid-organ transplantation about donor risk factors. N Engl J Med (2008) 2.83
Improvement in survival associated with adult-to-adult living donor liver transplantation. Gastroenterology (2007) 2.72
Liver transplantation from controlled non-heart-beating donors: an increased incidence of biliary complications. Transplantation (2003) 2.63
Synergistic reversal of intrahepatic HCV-specific CD8 T cell exhaustion by combined PD-1/CTLA-4 blockade. PLoS Pathog (2009) 2.57
Long-term management of the successful adult liver transplant: 2012 practice guideline by the American Association for the Study of Liver Diseases and the American Society of Transplantation. Liver Transpl (2013) 2.48
Immunosuppression regimen and the risk of acute rejection in HIV-infected kidney transplant recipients. Transplantation (2014) 2.26
Efficacy and safety of valganciclovir vs. oral ganciclovir for prevention of cytomegalovirus disease in solid organ transplant recipients. Am J Transplant (2004) 2.23
Structural and functional abnormalities in the islets isolated from type 2 diabetic subjects. Diabetes (2004) 2.22
Predicting outcome after liver transplantation: utility of the model for end-stage liver disease and a newly derived discrimination function. Transplantation (2004) 2.13
Liver transplant recipient survival benefit with living donation in the model for endstage liver disease allocation era. Hepatology (2011) 2.01
Survival following liver transplantation from non-heart-beating donors. Ann Surg (2004) 1.96
Liver transplantation for hepatocellular carcinoma validation of present selection criteria in predicting outcome. Liver Transpl (2004) 1.95
Donor morbidity after living donation for liver transplantation. Gastroenterology (2008) 1.90
Renal function after orthotopic liver transplantation is predicted by duration of pretransplantation creatinine elevation. Liver Transpl (2005) 1.87
p53: The Janus of autophagy? Nat Cell Biol (2008) 1.86
Center-level factors and racial disparities in living donor kidney transplantation. Am J Kidney Dis (2012) 1.82
Infusion of high-dose intravenous immunoglobulin fails to lower the strength of human leukocyte antigen antibodies in highly sensitized patients. Transplantation (2012) 1.78
Lack of benefit of pre-transplant locoregional hepatic therapy for hepatocellular cancer in the current MELD era. Liver Transpl (2006) 1.72
Geographic inequity in access to livers for transplantation. Transplantation (2011) 1.71
Endoscopic management of biliary complications after adult living donor liver transplantation. Am J Gastroenterol (2004) 1.68
Insulin independence following isolated islet transplantation and single islet infusions. Ann Surg (2003) 1.67
Zygomycosis in solid organ transplant recipients: a prospective, matched case-control study to assess risks for disease and outcome. J Infect Dis (2009) 1.62
Eculizumab and splenectomy as salvage therapy for severe antibody-mediated rejection after HLA-incompatible kidney transplantation. Transplantation (2014) 1.62
Genes involved in viral carcinogenesis and tumor initiation in hepatitis C virus-induced hepatocellular carcinoma. Mol Med (2008) 1.61
Laboratory test results after living liver donation in the adult-to-adult living donor liver transplantation cohort study. Liver Transpl (2011) 1.59
Transplantation: impact of pretransplant renal insufficiency. Liver Transpl (2008) 1.58
Operative parameters that predict the outcomes of hepatic transplantation. J Am Coll Surg (2003) 1.58
Validation of a current definition of early allograft dysfunction in liver transplant recipients and analysis of risk factors. Liver Transpl (2010) 1.56
Accelerated memory cell homeostasis during T cell depletion and approaches to overcome it. J Immunol (2006) 1.51
Use of EBV PCR for the diagnosis and monitoring of post-transplant lymphoproliferative disorder in adult solid organ transplant patients. Am J Transplant (2002) 1.49
GITR Blockade Facilitates Treg Mediated Allograft Survival. Transplantation (2009) 1.48
Herpes viruses in transplant recipients: HSV, VZV, human herpes viruses, and EBV. Infect Dis Clin North Am (2010) 1.47
Cutting edge: transplant tolerance induced by anti-CD45RB requires B lymphocytes. J Immunol (2007) 1.47
Longer-term outcomes after kidney transplantation from seronegative deceased donors at increased risk for blood-borne viral infection. Transplantation (2011) 1.42
Immune rejection after pancreatic islet cell transplantation: in vivo dual contrast-enhanced MR imaging in a mouse model. Radiology (2012) 1.41
Ascites after liver transplantation--a mystery. Liver Transpl (2004) 1.40
Promotion of allograft survival by CD4+CD25+ regulatory T cells: evidence for in vivo inhibition of effector cell proliferation. J Immunol (2004) 1.34
Cost-effectiveness of extending Medicare coverage of immunosuppressive medications to the life of a kidney transplant. Am J Transplant (2004) 1.33
Elevated portal vein drug levels of sirolimus and tacrolimus in islet transplant recipients: local immunosuppression or islet toxicity? Transplantation (2003) 1.32
Frailty and delayed graft function in kidney transplant recipients. Arch Surg (2012) 1.30
{beta}-Cell function following human islet transplantation for type 1 diabetes. Diabetes (2005) 1.28
The effect of a thyroid hormone infusion on vasopressor support in critically ill children with cessation of neurologic function. Crit Care Med (2004) 1.26
Biliary casts after orthotopic liver transplantation: clinical factors, treatment, biochemical analysis. Am J Gastroenterol (2003) 1.23
Interleukin-6 from intrahepatic cells of bone marrow origin is required for normal murine liver regeneration. Hepatology (2002) 1.23
Pretransplant model to predict posttransplant survival in liver transplant patients. Ann Surg (2002) 1.22
Living donor liver transplantation: summary of a conference at The National Institutes of Health. Liver Transpl (2002) 1.22
Delayed hepatocellular carcinoma model for end-stage liver disease exception score improves disparity in access to liver transplant in the United States. Hepatology (2015) 1.20
Allograft survival following adult-to-adult living donor liver transplantation. Am J Transplant (2004) 1.20
Summary report of a national conference: Evolving concepts in liver allocation in the MELD and PELD era. December 8, 2003, Washington, DC, USA. Liver Transpl (2004) 1.19
Expansion and conversion of human pancreatic ductal cells into insulin-secreting endocrine cells. Elife (2013) 1.19
Islet cell hormonal responses to hypoglycemia after human islet transplantation for type 1 diabetes. Diabetes (2005) 1.16
TGF-β-producing regulatory B cells induce regulatory T cells and promote transplantation tolerance. Eur J Immunol (2014) 1.15
Serum sickness after treatment with rabbit antithymocyte globulin in kidney transplant recipients with previous rabbit exposure. Am J Kidney Dis (2009) 1.15
Transplantation for type I diabetes: comparison of vascularized whole-organ pancreas with isolated pancreatic islets. Ann Surg (2004) 1.15
The report of a national conference on the wait list for kidney transplantation. Am J Transplant (2003) 1.14
Hospitalization rates before and after adult-to-adult living donor or deceased donor liver transplantation. Ann Surg (2010) 1.13
Superior survival using living donors and donor-recipient matching using a novel living donor risk index. Hepatology (2014) 1.12
MELD score is an important predictor of pretransplantation mortality in HIV-infected liver transplant candidates. Gastroenterology (2009) 1.11
Pre-liver transplantation locoregional adjuvant therapy for hepatocellular carcinoma as a strategy to improve longterm survival. J Am Coll Surg (2006) 1.11
A multicenter evaluation of safety of early extubation in liver transplant recipients. Liver Transpl (2007) 1.10
Liver and intestine transplantation: summary analysis, 1994-2003. Am J Transplant (2005) 1.09
Absence of cytomegalovirus-resistance mutations after valganciclovir prophylaxis, in a prospective multicenter study of solid-organ transplant recipients. J Infect Dis (2004) 1.08
Glycemic thresholds for activation of counterregulatory hormone and symptom responses in islet transplant recipients. J Clin Endocrinol Metab (2006) 1.04
The use of non-heart-beating donors for isolated pancreatic islet transplantation. Transplantation (2003) 1.03
Antibody-induced transplantation tolerance that is dependent on thymus-derived regulatory T cells. J Immunol (2006) 1.03
Factors differentially correlated with the outcome of liver transplantation in hcv+ and HCV- recipients. Transplantation (2004) 1.02
Risk for immune-mediated graft dysfunction in liver transplant recipients with recurrent HCV infection treated with pegylated interferon. Gastroenterology (2012) 1.01
The life-years saved by a deceased organ donor. Am J Transplant (2005) 1.00
Comparison of open, laparoscopic, and hand-assisted approaches to live-donor nephrectomy. Transplantation (2002) 0.99
Resistance to anti-CD45RB-induced tolerance in NOD mice: mechanisms involved. Transpl Int (2004) 0.99
Pharmacokinetic profile of ganciclovir after its oral administration and from its prodrug, valganciclovir, in solid organ transplant recipients. Clin Pharmacokinet (2005) 0.98
HLA sensitization in islet transplantation. Clin Transpl (2006) 0.97
Evidence for allograft rejection in an islet transplant recipient and effect on beta-cell secretory capacity. J Clin Endocrinol Metab (2007) 0.96
24-week oral ganciclovir prophylaxis in kidney recipients is associated with reduced symptomatic cytomegalovirus disease compared to a 12-week course. Transplantation (2006) 0.96
Clinical utility of cytomegalovirus viral load testing for predicting CMV disease in D+/R- solid organ transplant recipients. Am J Transplant (2004) 0.96
Risk factors for cytomegalovirus viremia and disease developing after prophylaxis in high-risk solid-organ transplant recipients. Transplantation (2004) 0.95
The faltering solid organ donor pool in the United States (2001-2010). World J Surg (2012) 0.95
Liver transplantation in children: update 2010. Pediatr Clin North Am (2010) 0.95
Determinants of transplant surgeons' willingness to provide organs to patients infected with HBV, HCV or HIV. Am J Transplant (2005) 0.95
Toward further expansion of the organ pool for adult liver recipients: splitting the cadaveric liver into right and left lobes. Transplantation (2002) 0.94